Aortic Aneurysm — Trimodal Prehabilitation for Aneurysm Surgery Study
Citation(s)
Arthur HM, Daniels C, McKelvie R, Hirsh J, Rush B Effect of a preoperative intervention on preoperative and postoperative outcomes in low-risk patients awaiting elective coronary artery bypass graft surgery. A randomized, controlled trial. Ann Intern Med. 2000 Aug 15;133(4):253-62.
Cunningham MA, Swanson V, O'Carroll RE, Holdsworth RJ Randomized clinical trial of a brief psychological intervention to increase walking in patients with intermittent claudication. Br J Surg. 2012 Jan;99(1):49-56. doi: 10.1002/bjs.7714. Epub 2011 Oct 28. Erratum in: Br J Surg. 2012 Jun;99(6):854. O'Caroll, R E [corrected to O'Carroll, R E].
Devine EC Effects of psychoeducational care for adult surgical patients: a meta-analysis of 191 studies. Patient Educ Couns. 1992 Apr;19(2):129-42.
Dunckley M, Ellard D, Quinn T, Barlow J Coronary artery bypass grafting: patients' and health professionals' views of recovery after hospital discharge. Eur J Cardiovasc Nurs. 2008 Mar;7(1):36-42. Epub 2007 Jul 23.
Mumford E, Schlesinger HJ, Glass GV The effect of psychological intervention on recovery from surgery and heart attacks: an analysis of the literature. Am J Public Health. 1982 Feb;72(2):141-51.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
